Every FDA inspection classification, counted.
Each record is FDA’s posted outcome for one inspection at one establishment — NAI, VAI or OAI, FDA’s labels, not SPEQ’s. Classifications post weeks to months after an inspection ends, so “recent” means recently classified, not recently inspected. Foreign sites are inspected far less often than US ones, so geography maps FDA’s reach, not global quality; and one firm can appear many times across sites and program areas.
Inspections by fiscal year, FY2009 to FY2027, over the current filters: 17 complete years, 0 still loading into SPEQ, FY2026, FY2027 partial. Highest total FY2011, 26,118.
* still posting — classifications post weeks to months after an inspection ends; this year is not comparable to closed years.
Records by product type over the current filters, sorted by volume: Food/Cosmetics 199,225 (5,777 OAI); Devices 51,244 (3,039 OAI); Drugs 41,000 (3,224 OAI); Biologics 32,664 (307 OAI); Veterinary 27,246 (1,264 OAI); Tobacco 1,372 (162 OAI).
Top places by record count over the current filters. This is where FDA inspects, which is not where quality is worst.
Ranked by count, never by rate. This maps FDA’s reach — where it inspects — not where quality is worst.
Counts below 10 are shown as “fewer than 10” on the public page. Professional readers see exact counts.